| Kathleen S Farah, MD | |
|
2321 Stout Rd, Menomonie, WI 54751-7003 | |
| (715) 235-5531 | |
| (715) 233-7645 |
| Full Name | Kathleen S Farah |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 42 Years |
| Location | 2321 Stout Rd, Menomonie, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578507273 | NPI | - | NPPES |
| 30563100 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 25580 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baldwin Area Medical Center Inc | 7911800586 | 66 |
News Archive
While this is hardly life-threatening, the doctors say sock-line bands in some cases developed at just one week leaving raised, reddish markings around the ankle or leg.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today presented an analysis of baseline data from the Phase 3 DEFEND-1 clinical trial of otelixizumab in patients with autoimmune new onset type 1 diabetes.
Scientists report promising activity of a novel drug that targets a key molecular driver of clear cell renal cell carcinoma (ccRCC) in patients with metastatic disease.
Technique that could derive human embryonic stem cells without destroying human embryos, recently published in the journal Nature, could impede funding for stem cell research in this week's "Health on the Hill From kaisernetwork.org and CQ."
› Verified 6 days ago
| Entity Name | Baldwin Area Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467496133 PECOS PAC ID: 7911800586 Enrollment ID: O20040310000505 |
News Archive
While this is hardly life-threatening, the doctors say sock-line bands in some cases developed at just one week leaving raised, reddish markings around the ankle or leg.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today presented an analysis of baseline data from the Phase 3 DEFEND-1 clinical trial of otelixizumab in patients with autoimmune new onset type 1 diabetes.
Scientists report promising activity of a novel drug that targets a key molecular driver of clear cell renal cell carcinoma (ccRCC) in patients with metastatic disease.
Technique that could derive human embryonic stem cells without destroying human embryos, recently published in the journal Nature, could impede funding for stem cell research in this week's "Health on the Hill From kaisernetwork.org and CQ."
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen S Farah, MD 2321 Stout Rd, Menomonie, WI 54751-7003 Ph: (715) 235-5531 | Kathleen S Farah, MD 2321 Stout Rd, Menomonie, WI 54751-7003 Ph: (715) 235-5531 |
News Archive
While this is hardly life-threatening, the doctors say sock-line bands in some cases developed at just one week leaving raised, reddish markings around the ankle or leg.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today presented an analysis of baseline data from the Phase 3 DEFEND-1 clinical trial of otelixizumab in patients with autoimmune new onset type 1 diabetes.
Scientists report promising activity of a novel drug that targets a key molecular driver of clear cell renal cell carcinoma (ccRCC) in patients with metastatic disease.
Technique that could derive human embryonic stem cells without destroying human embryos, recently published in the journal Nature, could impede funding for stem cell research in this week's "Health on the Hill From kaisernetwork.org and CQ."
› Verified 6 days ago
Jennifer A Strong, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3603 Schneider Ave Se, Menomonie, WI 54751 Phone: 715-233-6400 | |
Brandon L. Parkhurst, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3603 Schneider Ave Se, Menomonie, WI 54751 Phone: 715-233-6400 | |
Mark E. Deyo-svendsen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2321 Stout Rd, Menomonie, WI 54751 Phone: 715-235-5531 Fax: 715-233-7645 | |
Dr. Terrence John Witt, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2321 Stout Rd, Menomonie, WI 54751 Phone: 715-235-5531 | |
Jessica Jeanne Winterfeldt, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 2321 Stout Rd, Menomonie, WI 54751 Phone: 715-235-5531 | |
Michael R. Phillips, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2321 Stout Rd, Menomonie, WI 54751 Phone: 715-235-5531 Fax: 715-233-7645 | |
Ms. Jill Anne Hasenberg-gindt, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4076 Kothlow Ave, Menomonie, WI 54751 Phone: 715-235-4537 Fax: 715-235-4535 |